Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital

MLA

Nancy Monroy-Jaramillo, et al. “Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital.” Pharmacogenomics, vol. 22, Oct. 2021, pp. 983–96. EBSCOhost, https://doi.org/10.2217/pgs-2021-0081.

APA

Nancy Monroy-Jaramillo, Pedro Dorado, Ingrid Fricke-Galindo, Irma Susana Rojas-Tomé, Marisol López-López, Alberto Ortega-Vázquez, Helgi Jung-Cook, Eva M Peñas-Lledó, Iris E. Martínez-Juárez, & Adrián LLerena. (2021). Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics, 22, 983–996. https://doi.org/10.2217/pgs-2021-0081

Chicago

Nancy Monroy-Jaramillo, Pedro Dorado, Ingrid Fricke-Galindo, Irma Susana Rojas-Tomé, Marisol López-López, Alberto Ortega-Vázquez, Helgi Jung-Cook, Eva M Peñas-Lledó, Iris E. Martínez-Juárez, and Adrián LLerena. 2021. “Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital.” Pharmacogenomics 22 (October): 983–96. doi:10.2217/pgs-2021-0081.